Dimensional Fund Advisors LP increased its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 0.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,450,463 shares of the health services provider's stock after buying an additional 18,059 shares during the period. Dimensional Fund Advisors LP owned about 0.88% of The Cigna Group worth $676,655,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also modified their holdings of CI. TCTC Holdings LLC acquired a new stake in shares of The Cigna Group in the fourth quarter worth approximately $25,000. Collier Financial acquired a new stake in shares of The Cigna Group in the fourth quarter valued at about $32,000. ORG Wealth Partners LLC acquired a new position in The Cigna Group during the fourth quarter worth about $34,000. Compagnie Lombard Odier SCmA acquired a new stake in The Cigna Group in the 4th quarter valued at about $37,000. Finally, Heck Capital Advisors LLC acquired a new position in shares of The Cigna Group during the 4th quarter worth approximately $53,000. Institutional investors and hedge funds own 86.99% of the company's stock.
Wall Street Analyst Weigh In
CI has been the topic of a number of analyst reports. Royal Bank of Canada set a $355.00 price objective on The Cigna Group in a research report on Friday, January 31st. Robert W. Baird decreased their target price on shares of The Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Barclays decreased their price target on shares of The Cigna Group from $420.00 to $339.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. UBS Group cut their price objective on The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, February 3rd. Finally, Raymond James reiterated a "strong-buy" rating and issued a $360.00 target price (down from $415.00) on shares of The Cigna Group in a report on Friday, January 31st. Two research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and three have issued a strong buy rating to the company's stock. According to MarketBeat, The Cigna Group currently has an average rating of "Buy" and an average target price of $373.56.
Get Our Latest Report on The Cigna Group
Insider Buying and Selling at The Cigna Group
In other news, CEO David Cordani sold 26,527 shares of the stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the sale, the chief executive officer now owns 127,767 shares in the company, valued at approximately $39,367,568.04. This trade represents a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Nicole S. Jones sold 4,904 shares of The Cigna Group stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the sale, the insider now directly owns 29,421 shares in the company, valued at approximately $9,065,198.52. The trade was a 14.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,751 shares of company stock worth $13,603,991 in the last quarter. 0.70% of the stock is owned by insiders.
The Cigna Group Price Performance
CI traded down $0.97 on Thursday, hitting $335.72. 478,560 shares of the company were exchanged, compared to its average volume of 1,692,643. The firm has a market capitalization of $91.88 billion, a P/E ratio of 27.41, a price-to-earnings-growth ratio of 0.98 and a beta of 0.51. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The business's fifty day moving average is $318.14 and its 200 day moving average is $310.78. The Cigna Group has a fifty-two week low of $262.03 and a fifty-two week high of $370.83.
The Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the previous year, the business posted $6.79 earnings per share. As a group, sell-side analysts anticipate that The Cigna Group will post 29.77 EPS for the current year.
The Cigna Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a yield of 1.80%. The Cigna Group's dividend payout ratio is currently 49.35%.
The Cigna Group Company Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Recommended Stories

Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.